The Hsp90ab1 Knockout C8-D1A Polyclonal Cells represent a CRISPR/Cas9-mediated polyclonal knockout cell population derived from the C8-D1A mouse cerebellar astrocyte cell line, engineered for loss-of-function studies of the Hsp90ab1 gene. This heterogeneous pool of edited cells provides a versatile model system for investigating the pleiotropic roles of the molecular chaperone Hsp90ab1 in cellular signaling, proteostasis, and astrocyte biology without requiring single-cell clonal isolation. The targeted disruption of the Hsp90ab1 locus abrogates expression of the constitutively active Hsp90beta isoform, enabling researchers to dissect its specific contributions to client protein maturation and signaling network integrity. This polyclonal format preserves the natural genetic diversity of the parental line while ensuring robust knockout effects across the population, making it suitable for high-throughput screening, pathway analysis, and comparative studies with wild-type controls.
The host C8-D1A cell line is a well-characterized, immortalized astrocyte line derived from postnatal day 8 mouse cerebellum. These cells retain key features of primary astrocytes, including expression of glial fibrillary acidic protein (GFAP) and glutamate transporters, and are widely employed in neurobiology research to model astrocyte-mediated support of neuronal function, maintenance of the blood?Cbrain barrier, and regulation of synaptic transmission. Their cerebellar origin also makes them relevant for studies of motor coordination and Purkinje cell?Castrocyte interactions. The C8-D1A line offers a reproducible, scalable platform for investigating astrocyte-specific molecular mechanisms in health and disease, particularly in the context of neuroinflammation, metabolic coupling, and neuroprotection.
Hsp90ab1 encodes the beta isoform of the 90 kDa heat shock protein, a highly conserved, ubiquitously expressed molecular chaperone essential for the folding, stabilization, and activation of numerous client proteins, including kinases (e.g., AKT, ERK, Src), steroid hormone receptors (e.g., glucocorticoid receptor), and transcription factors (e.g., p53, HIF-1??). Under homeostatic and stress conditions, Hsp90ab1 functions in dynamic multiprotein complexes with co-chaperones such as Hsp70, Hsp40, p23, AHA1, CDC37, and FKBP52 to facilitate client maturation and prevent aggregation. Its activity is primarily regulated by the transcription factor HSF1, which is activated by diverse cellular stresses (heat shock, oxidative stress, oncogenic signaling). Hsp90ab1 is a critical node in multiple signal transduction cascades, including the PI3K/AKT/mTOR, RAS/RAF/MEK/ERK, JAK/STAT, and IKK/NF-??B pathways. Consequently, genetic disruption of Hsp90ab1 leads to destabilization and proteasomal degradation of its clients, profoundly impairing proliferative, survival, and inflammatory signaling.
In the context of C8-D1A astrocytes, Hsp90ab1 knockout is expected to have pronounced effects on stress responses and neuroinflammatory signaling networks. Astrocytes are key mediators of CNS homeostasis, and their dysfunction is implicated in Alzheimer??s disease, Parkinson??s disease, and other neurodegenerative conditions. Loss of Hsp90ab1 function in these cells may compromise the chaperoning of critical neuroprotective clients and alter NF-??B-dependent cytokine production, thereby providing a cellular model to study the intersection of proteostasis and neuroinflammation. This polyclonal knockout population is particularly valuable for evaluating how chaperone dysfunction contributes to astrocyte reactivity and synaptic support deficits, and for screening potential Hsp90-targeted therapeutic compounds in a disease-relevant glial context.
This knockout product is designed for a wide range of research applications, including cancer biology, neurodegeneration, protein folding studies, drug target validation, and stress response mechanisms. Its use enables detailed phenotypic analyses through western blotting, RT-qPCR, immunofluorescence, cell viability and apoptosis assays, co-immunoprecipitation, kinase activity measurements, and reporter gene assays. By supplying a defined, gene-edited astrocyte population, it accelerates functional studies of Hsp90ab1-dependent signaling and client protein dynamics. For additional technical details, batch-specific data, or customized solutions, please contact Ascent Research.
